| 摘要 |
PURPOSE: To obtain a pharmaceutical composition for treating dementia and depression. CONSTITUTION: This pharmaceutical composition comprises γ-linolenic acid or dihomo-γ-linolenic acid and bioavailable selenium and arbitrarily, further, an 18:4 n-3 or higher essential fatty acid and/or bioavailable zinc. |
